Handel E. Evans

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA.

Part of Quintiles Transnational Corp., Pharmaceutical Marketing Services, Inc. provides a range of information services to pharmaceutical and health care companies. The private company is based in New York, NY. Pharmaceutical Marketing Services was acquired by Quintiles Transnational Corp. on March 30, 1999 for $189.59 million.

Part of IQVIA Holdings, Inc., Walsh International, Inc. is a private company that develops marketing and sales information systems. The company is based in Newtown, PA. Walsh International was acquired by Cognizant Corp on August 31, 1998 for $184.63 million.

Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996.

Adeptio Pharmaceuticals Ltd. provides pharmaceutical research and development services. The CEO of the British company is Mark Evans.